410 related articles for article (PubMed ID: 27070574)
21. CD147: regulator of hyaluronan signaling in invasiveness and chemoresistance.
Grass GD; Dai L; Qin Z; Parsons C; Toole BP
Adv Cancer Res; 2014; 123():351-73. PubMed ID: 25081536
[TBL] [Abstract][Full Text] [Related]
22. Transforming growth factor-β1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cells.
Li L; Qi L; Liang Z; Song W; Liu Y; Wang Y; Sun B; Zhang B; Cao W
Int J Mol Med; 2015 Jul; 36(1):113-22. PubMed ID: 26005723
[TBL] [Abstract][Full Text] [Related]
23. CD44 and hyaluronan engagement promotes dexamethasone resistance in human myeloma cells.
Ohwada C; Nakaseko C; Koizumi M; Takeuchi M; Ozawa S; Naito M; Tanaka H; Oda K; Cho R; Nishimura M; Saito Y
Eur J Haematol; 2008 Mar; 80(3):245-50. PubMed ID: 18081709
[TBL] [Abstract][Full Text] [Related]
24. Design and syntheses of hyaluronan oligosaccharide conjugates as inhibitors of CD44-Hyaluronan binding.
Lu X; Huang X
Glycoconj J; 2015 Oct; 32(7):549-56. PubMed ID: 25997408
[TBL] [Abstract][Full Text] [Related]
25. Hyaluronan regulates ceruloplasmin production by gliomas and their treatment-resistant multipotent progenitors.
Tye SL; Gilg AG; Tolliver LB; Wheeler WG; Toole BP; Maria BL
J Child Neurol; 2008 Oct; 23(10):1221-30. PubMed ID: 18952589
[TBL] [Abstract][Full Text] [Related]
26. Hyaluronan-CD44 axis orchestrates cancer stem cell functions.
Skandalis SS; Karalis TT; Chatzopoulos A; Karamanos NK
Cell Signal; 2019 Nov; 63():109377. PubMed ID: 31362044
[TBL] [Abstract][Full Text] [Related]
27. CD44: More than a mere stem cell marker.
Morath I; Hartmann TN; Orian-Rousseau V
Int J Biochem Cell Biol; 2016 Dec; 81(Pt A):166-173. PubMed ID: 27640754
[TBL] [Abstract][Full Text] [Related]
28. miRNA expression profile of colon cancer stem cells compared to non-stem cells using the SW1116 cell line.
Fang Y; Xiang J; Chen Z; Gu X; Li Z; Tang F; Zhou Z
Oncol Rep; 2012 Dec; 28(6):2115-24. PubMed ID: 23007737
[TBL] [Abstract][Full Text] [Related]
29. Hyaluronan facilitates invasion of colon carcinoma cells in vitro via interaction with CD44.
Kim HR; Wheeler MA; Wilson CM; Iida J; Eng D; Simpson MA; McCarthy JB; Bullard KM
Cancer Res; 2004 Jul; 64(13):4569-76. PubMed ID: 15231668
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer.
Gwak JM; Kim HJ; Kim EJ; Chung YR; Yun S; Seo AN; Lee HJ; Park SY
Breast Cancer Res Treat; 2014 Aug; 147(1):39-49. PubMed ID: 25086633
[TBL] [Abstract][Full Text] [Related]
31. HER2 interacts with CD44 to up-regulate CXCR4 via epigenetic silencing of microRNA-139 in gastric cancer cells.
Bao W; Fu HJ; Xie QS; Wang L; Zhang R; Guo ZY; Zhao J; Meng YL; Ren XL; Wang T; Li Q; Jin BQ; Yao LB; Wang RA; Fan DM; Chen SY; Jia LT; Yang AG
Gastroenterology; 2011 Dec; 141(6):2076-2087.e6. PubMed ID: 21925125
[TBL] [Abstract][Full Text] [Related]
32. CD44S-hyaluronan interactions protect cells resulting from EMT against anoikis.
Cieply B; Koontz C; Frisch SM
Matrix Biol; 2015 Oct; 48():55-65. PubMed ID: 25937513
[TBL] [Abstract][Full Text] [Related]
33. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.
Xia H; Hui KM
Cancer Gene Ther; 2012 Nov; 19(11):723-30. PubMed ID: 22975591
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-200c overexpression plays an inhibitory role in human pancreatic cancer stem cells by regulating epithelial-mesenchymal transition.
Ma C; Ding YC; Yu W; Wang Q; Meng B; Huang T
Minerva Med; 2015 Aug; 106(4):193-202. PubMed ID: 26081037
[TBL] [Abstract][Full Text] [Related]
35. Hyaluronic acid synthase-1 expression regulates bladder cancer growth, invasion, and angiogenesis through CD44.
Golshani R; Lopez L; Estrella V; Kramer M; Iida N; Lokeshwar VB
Cancer Res; 2008 Jan; 68(2):483-91. PubMed ID: 18199543
[TBL] [Abstract][Full Text] [Related]
36. The Role of CD44 and Cancer Stem Cells.
Wang L; Zuo X; Xie K; Wei D
Methods Mol Biol; 2018; 1692():31-42. PubMed ID: 28986884
[TBL] [Abstract][Full Text] [Related]
37. CD147/EMMPRIN and CD44 are potential therapeutic targets for metastatic prostate cancer.
Hao JL; Cozzi PJ; Khatri A; Power CA; Li Y
Curr Cancer Drug Targets; 2010 May; 10(3):287-306. PubMed ID: 20370680
[TBL] [Abstract][Full Text] [Related]
38. miR-21 and miR-145 cooperation in regulation of colon cancer stem cells.
Yu Y; Nangia-Makker P; Farhana L; G Rajendra S; Levi E; Majumdar AP
Mol Cancer; 2015 May; 14():98. PubMed ID: 25928322
[TBL] [Abstract][Full Text] [Related]
39. Role of hyaluronan-mediated CD44 signaling in head and neck squamous cell carcinoma progression and chemoresistance.
Wang SJ; Bourguignon LY
Am J Pathol; 2011 Mar; 178(3):956-63. PubMed ID: 21356346
[TBL] [Abstract][Full Text] [Related]
40. Dynamic interplay between breast cancer cells and normal endothelium mediates the expression of matrix macromolecules, proteasome activity and functional properties of endothelial cells.
Gialeli Ch; Viola M; Barbouri D; Kletsas D; Passi A; Karamanos NK
Biochim Biophys Acta; 2014 Aug; 1840(8):2549-59. PubMed ID: 24582970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
